Roche Holding said mid-stage trials of its experimental oral skin-cancer drug vismodegib showed the medicine to be successful in shrinking tumors in some patients.
WSJ.com: What's News US, Wall Street Journal
Mon, 03/21/2011 - 8:22am
Roche Holding said mid-stage trials of its experimental oral skin-cancer drug vismodegib showed the medicine to be successful in shrinking tumors in some patients.